Dictionaries Armenian-English English-Armenian MeSH Feedback
UMLS. CSP-HL7-ICD9CM-NCI-NDFRT-RXNORM
%
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
B B B0 B1 B4 B7 B8 BA BB BC BD BE BF BG BH BI BK BL BM BN BO BP BR BS BT BU BV BW BX BY BZ
selected terms: 4,011
 << Prev ▫ 1 ▫ 2 ▫ 3 ▫ 4 ▫ 5 ▫ .. ▫ 41 ▫ Next >>
 page 2 of 41

101. 2-Bromo-alpha-ergocryptine Mesylate
[The mesylate salt form of bromocriptine, a semisynthetic, ergot alkaloid with antiparkinson and lactation inhibitory activity. Bromocriptine selectively binds to and activates the postsynaptic dopamine D2-like receptors in the corpus striatum of the central nervous system (CNS). D2-like receptors are coupled to inhibitory G-proteins, which inhibit adenylyl cyclase, thereby preventing signal transduction mediated via cAMP and leading to an inhibitory effect on neurotransmission. This improves Parkinson symptoms, such as dyskinesia. Bromocriptine also has an inhibitory effect on the anterior pituitary gland, which results in blockage of prolactin secretion, thereby suppressing lactation. ( NCI )] (UMLS (NCI) C0546852) =Organic Chemical; Pharmacologic Substance =2-Bromo-alpha-ergocryptine;
=BROMOCRIPTINE MESYLATE 2.5 MG;
BROMOCRIPTINE MESYLATE 5 MG
151. 60-69% BDY BRN/30-39% 3D
[ ] (UMLS (ICD9CM) C0161358) =Injury or Poisoning
102. 2-Butenoic acid, 3-bromo-4-(4-methoxyphenyl)-4-oxo-, sodium salt, (Z)- (9CI)
(UMLS (NCI) C0893303) Acrylic acid, 3-p-anisoyl-3-bromo-, sodium salt;
Sodium Bromebrate;
Sodium cis-Beta-4-methoxybenzoyl-beta-bromacrylate =Organic Chemical; Pharmacologic Substance
152. 60-69% BDY BRN/40-49% 3D
[ ] (UMLS (ICD9CM) C0161359) =Injury or Poisoning
103. 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol
[antihypertensive agent; nonpeptide angiotension 1 subtype; angiotension 2 receptor antagonist/inhibitor. ( CSP )] (UMLS (NCI) C0126174) =Organic Chemical; Pharmacologic Substance ;
=antihypertensive agent;
biphenyl compound;
imidazole;
Tetrazoles;
[CV805] ANGIOTENSIN II INHIBITORS;
=2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, Monopotassium Salt;
LOSARTAN 25 MG;
LOSARTAN 50 MG
153. 60-69% BDY BRN/50-59% 3D
[ ] (UMLS (ICD9CM) C0161360) =Injury or Poisoning
104. 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, Monopotassium Salt
[The potassium salt form of losartan, a non-peptide angiotensin II antagonist with antihypertensive activity. Losartan potassium selectively and competitively blocks the binding of angiotensin II to the angiotensin I (AT1) receptor. Angiotensin II, formed from angiotensin I by angiotensin-converting enzyme (ACE), stimulates the adrenal cortex to synthesize and secrete aldosterone, which decreases the excretion of sodium and increases the excretion of potassium. Angiotensin II also acts as a vasoconstrictor in vascular smooth muscle. Losartan potassium, by blocking the binding of angiotensin II to the AT 1 receptor, promotes vasodilatation and decreases the effects of aldosterone. ( NCI )] (UMLS (NCI) C0700492) =Organic Chemical; Pharmacologic Substance ;
=2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol;
=LOSARTAN POTASSIUM 25 MG;
LOSARTAN POTASSIUM 50 MG;
LOSARTAN POTASSIUM 100 MG;
154. 60-69% BDY BRN/60-69% 3D
[ ] (UMLS (ICD9CM) C0161361) =Injury or Poisoning
105. 2-[bis(2-chloroethyl)amino]-3-(2-chloroethyl)tetrahydro-2H-1,3,2-oxaphosphorine 2-oxide
[An orally bioavailable oxazaphosphorine prodrug with antineoplastic activity. Trofosfamide (TFF) is metabolized predominantly to the cyclophosphamide analogue ifosfamide (IFO), which is then metabolized by liver cytochrome P450s to the active isophosphoramide mustard (IPM). IPM alkylates DNA to form DNA-DNA cross-links, which may result in inhibition of DNA, RNA and protein synthesis, and ultimately lead to tumor cell apoptosis. ( NCI )] (UMLS (NCI) C0077375) =Organic Chemical; Pharmacologic Substance ;
155. 70-79% BDY BRN/10-19% 3D
[ ] (UMLS (ICD9CM) C0161364) =Injury or Poisoning
106. 2-[bis(2-chloroethyl)amino]-4-hydroperoxytetrahydro-2H-1,3,2-oxazaphosphorine 2-oxide
[The active metabolite of the nitrogen mustard cyclophosphamide with potent antineoplastic and immunosuppressive properties. Perfosfamide alkylates DNA, thereby inhibiting DNA replication and RNA and protein synthesis. (NCI04) ( NCI )] (UMLS (NCI) C0163054) =Organophosphorus Compound; Pharmacologic Substance ;
156. 70-79% BDY BRN/20-29% 3D
[ ] (UMLS (ICD9CM) C0161365) =Injury or Poisoning
107. 20-29% BDY BRN/10-19% 3D
[ ] (UMLS (ICD9CM) C0161334) =Injury or Poisoning
157. 70-79% BDY BRN/3 DEG NOS
[ ] (UMLS (ICD9CM) C0161363) =Injury or Poisoning
108. 20-29% BDY BRN/20-29% 3D
[ ] (UMLS (ICD9CM) C0161335) =Injury or Poisoning
158. 70-79% BDY BRN/30-39% 3D
[ ] (UMLS (ICD9CM) C0161366) =Injury or Poisoning
109. 20-29% BDY BRN/3 DEG NOS
[ ] (UMLS (ICD9CM) C0161333) =Injury or Poisoning
159. 70-79% BDY BRN/40-49% 3D
[ ] (UMLS (ICD9CM) C0161367) =Injury or Poisoning
110. 2B1
[A monoclonal antibody with potential antineoplastic activity. Specific for both the immunoglobulin G (IgG) receptor CD16 and c-erbB-2, bispecific antibody 2B1 may enhance cellular immune responses against c-erbB-2-positive cells, resulting in increased tumor cell lysis. (NCI04) ( NCI )] (UMLS (NCI) C0338223) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
160. 70-79% BDY BRN/50-59% 3D
[ ] (UMLS (ICD9CM) C0161368) =Injury or Poisoning
111. 2beta,16beta-Dipiperidino-5alpha-androstane-3alpha,17beta-diol Diacetate Dimethobromide
[The bromide salt form of pancuronium, a synthetic, long-acting ammonio steroid muscle relaxant with curarimimetic, some antimuscarinic and sympathomimetic effects. Pancuronium bromide competitively binds to the nicotinic receptor at the neuromuscular junction, thereby preventing acetylcholine binding and resulting in skeletal muscle relaxation and paralysis. ( NCI )] (UMLS (NCI) C0030311) =Steroid; Pharmacologic Substance ;
=PANCURONIUM;
=PANCURONIUM BROMIDE 1 MG/ML;
PANCURONIUM BROMIDE 2 MG/ML
161. 70-79% BDY BRN/60-69% 3D
[ ] (UMLS (ICD9CM) C0161369) =Injury or Poisoning
112. 3,3'-[(1,1'-Biphenyl)-4,4'-Diylbis(Azo)]Bis(5-Amino-4-Hydroxy)- 2,7-Naphthalenedisulfonic Acid, Tetrasodium Salt
[A Benzidine-based azo dye that is metabolized to free Benzidine in vivo. Direct blue 6 is primarily used for the dyeing of textiles, leather and paper. Benzidine and its metabolic derivatives have been detected in the urine of workers exposed to Benzidine-based dyes. Exposure to this dye is strongly associated with the occurrence of bladder cancer. (NCI05) ( NCI )] (UMLS (NCI) C0058439) =Organic Chemical; Pharmacologic Substance ;
162. 70-79% BDY BRN/70-79% 3D
[ ] (UMLS (ICD9CM) C0161370) =Injury or Poisoning
113. 3,4-Benzpyrene
[A crystalline, aromatic hydrocarbon consisting of five fused benzene rings and formed during the incomplete combustion of organic matter. 3,4-Benzpyrene is primarily found in gasoline and diesel exhaust, cigarette smoke, coal tar and coal tar pitch, charcoal-broiled foods and certain other foods, amino acids, fatty acids and carbohydrate pyrolysis products, soot smoke, creosote oil, petroleum asphalt and shale oils. This substance is used only for research purposes. 3,4-Benzpyrene is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0005052) =Organic Chemical; Hazardous or Poisonous Substance
163. 7B4 Antigen
[Encoded by human CDH5 Gene (CDH Family), 784-amino acid 87.5 kD (precursor) Vascular Endothelial Cadherin is a Ca(2+)-dependent homophilic endothelial cell-cell adhesion type I membrane glycoprotein composed of five extracellular cadherin repeats, a transmembrane region, and a highly conserved cytoplasmic tail. Expressed specifically in endothelial cells and brain, VE-Cadherin is found mainly at cell-cell boundaries, associated with intercellular junctions. CDH5 may play a role in endothelial cell cohesion and organization of intercellular junctions. CDH5/beta-catenin signaling may control endothelial survival. CDH5 associates with alpha-catenin, forming a link to the cytoskeleton. (from LocusLink, SWISS-PROT, OMIM, and NCI) ( NCI )] (UMLS (NCI) C0300423) =Amino Acid, Peptide, or Protein; Immunologic Factor
114. 3,5-Bis(acetylamino)-2,4,6-triiodobenzoic Acid
[A commonly used x-ray contrast medium. As DIATRIZOATE MEGLUMINE and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography. ( MSH )] (UMLS (NCI) C0012004) =Organic Chemical; Indicator, Reagent, or Diagnostic Aid ;
=[DX102] IONIC CONTRAST MEDIA;
=1-Deoxy-1-(methylamino)-D-glucitol 3,5-diacetamido-2,4,6-triiodobenzoate (salt);
3,5-Diacetamido-2,4,6-triiodobenzoic Acid, Sodium Salt
164. 80-89% BDY BRN/10-19% 3D
[ ] (UMLS (ICD9CM) C0161373) =Injury or Poisoning
115. 3,6-bis-(2-piperidinoethoxyl)acridine trihydrochloride
(UMLS (NCI) C0055843) =Organic Chemical; Pharmacologic Substance ;
165. 80-89% BDY BRN/20-29% 3D
[ ] (UMLS (ICD9CM) C0161374) =Injury or Poisoning
116. 30-39% BDY BRN/10-19% 3D
[ ] (UMLS (ICD9CM) C0161338) =Injury or Poisoning
166. 80-89% BDY BRN/3 DEG NOS
[ ] (UMLS (ICD9CM) C0161372) =Injury or Poisoning
117. 30-39% BDY BRN/20-29% 3D
[ ] (UMLS (ICD9CM) C0161339) =Injury or Poisoning
167. 80-89% BDY BRN/30-39% 3D
[ ] (UMLS (ICD9CM) C0161375) =Injury or Poisoning
118. 30-39% BDY BRN/3 DEG NOS
[ ] (UMLS (ICD9CM) C0161337) =Injury or Poisoning
168. 80-89% BDY BRN/40-49% 3D
[ ] (UMLS (ICD9CM) C0161376) =Injury or Poisoning
119. 30-39% BDY BRN/30-39% 3D
[ ] (UMLS (ICD9CM) C0161340) =Injury or Poisoning
169. 80-89% BDY BRN/50-59% 3D
[ ] (UMLS (ICD9CM) C0161377) =Injury or Poisoning
120. 3B-O-(4-O-Acetyl-2,6-dideoxy-3-C-methyl-alpha-L-arabino-hexopyranosyl)-7-methylolivomycin D
[A glycosidic antineoplastic antibiotic isolated from the bacterium Streptomyces griseus. Chromomycin A3 reversibly binds to guanine-cytosine (G-C) base pairs in the minor groove of DNA, thereby inhibiting RNA synthesis. This agent is used as a fluorescent chromosome dye. (NCI04) ( NCI )] (UMLS (NCI) C0040563) =Organic Chemical; Antibiotic
170. 80-89% BDY BRN/60-69% 3D
[ ] (UMLS (ICD9CM) C0161378) =Injury or Poisoning
121. 3beta-Hydroxy-11-oxoolean-12-en-30-oic Acid Hydrogen cis-1,2-cyclohexanedicarboxylate
(UMLS (NCI) C0055717) =Organic Chemical; Pharmacologic Substance ;
171. 80-89% BDY BRN/70-79% 3D
[ ] (UMLS (ICD9CM) C0161379) =Injury or Poisoning
122. 3beta-Hydroxyandrost-5-en-17-one
[major C19 steroid produced by the adrenal cortex; also produced in small quantities in the testis and the ovary; dehydroepiandrosterone (DHEA) can be converted to testosterone; androstenedione; estradiol; and estrone; most of DHEA is sulfated (dehydroepiandrosterone sulfate) before secretion. ( CSP )] (UMLS (NCI) C0011185) =Steroid; Pharmacologic Substance; Hormone =adrenal cortex hormone;
androgen;
[HS000] HORMONES / SYNTHETICS / MODIFIERS;
Unclassified Ingredients =DEHYDROEPIANDROSTERONE (DHEA) CAP/TAB;
172. 80-89% BDY BRN/80-89% 3D
[ ] (UMLS (ICD9CM) C0161380) =Injury or Poisoning
123. 3beta-N-1-(N-(3-(4-Aminobutyl))-1,3-diaminopropane)-7alpha,24-dihydroxy-5alpha-cholestane 24-sulfate
(UMLS (NCI) C0213314) =Steroid; Pharmacologic Substance
173. 8B-[(Methylthio)methyl]-6-propylergoline Monomethanesulfonate
[A semi-synthetic ergot derivative and a dopamine agonist with antiparkinson property. Pergolide mesylate binds to and activates dopamine receptor subtypes D1 and D2, resulting in prolactin secretion inhibition, transient increase in serum concentration of growth hormone, and decrease in serum concentration of luteinizing hormone. Direct stimulation of postsynaptic dopamine receptors in the nigrostriatal system, may account for this agent's antiparkinson activity. ( NCI )] (UMLS (NCI) C0031008) =Organic Chemical; Pharmacologic Substance =PERGOLIDE;
=PERGOLIDE MESYLATE 0.05 MG;
PERGOLIDE MESYLATE 0.25 MG;
PERGOLIDE MESYLATE 1 MG
124. 4,4'-Bis(dimethylamino)diphenylmethane
[A yellow colored, combustible leaflet material that emits toxic fumes of nitrogen oxides when heated to decomposition. Michler's base is used as a chemical intermediate in the manufacture of dyes and for its hydrochloric salt and is also used as an analytical reagent in the determination of lead. Exposure to Michler's base irritates the skin and eyes and can lead to methemoglobinemia and respiratory tract distress. Michler's base is reasonably anticipated to be a human carcinogen. (NCI05) ( NCI )] (UMLS (NCI) C0067320) =Organic Chemical; Pharmacologic Substance ;
174. 9,13b-Dihydro-1H-dibenz(c,f)imidazo(1,5-a)azepin-3-amine Hydrochloride
[An histamine H1 receptor antagonist without sedative activity. Epinastine hydrochloride blocks the histamine H1 receptor and inhibits the release of histamine from mast cells. This prevents the typical allergic symptoms that are caused by histamine activity on capillaries, skin, mucous membranes, and on gastrointestinal and bronchial smooth muscles. Typical histamine activities include vasodilation, bronchoconstriction, increased vascular permeability, pain, itching, and spasmodic contractions of gastrointestinal smooth muscles. Epinastine also has affinity for the histamine H2, 5-HT2, and the alpha-1, alpha-2 adrenergic receptors. ( NCI )] (UMLS (NCI) C0772294) Alesion;
Epinastine Hydrochloride;
=Organic Chemical; Pharmacologic Substance ;
125. 4,7-Bis(dimethylamino)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide Monohydrochloride
[The hydrochloride salt form of minocycline, a broad-spectrum, semi-synthetic tetracycline antibiotic with antimicrobial properties. Minocycline hydrochloride exerts its bacteriostatic effect by binding to bacterial 30S ribosomal subunit and prevents binding of aminoacyl-tRNA to mRNA on the ribosomes during elongation step of protein translation. This leads to an inhibition of bacterial protein synthesis and consequently cell growth. ( NCI )] (UMLS (NCI) C0026186) =Organic Chemical; Antibiotic =MINOCYCLINE;
=MINOCYCLINE HYDROCHLORIDE 50 MG;
MINOCYCLINE HYDROCHLORIDE 100 MG;
MINOCYCLINE HYDROCHLORIDE 75 MG;
MINOCYCLINE HYDROCHLORIDE 50 MG/5ML;
MINOCYCLINE HYDROCHLORIDE 1 MG
175. 9-Beta-D-arabinofuranosyl-9H-purine-6-amine Monohydrate
[A nucleoside antibiotic isolated from the bacterium Streptomyces antibioticus with antineoplastic activity. Vidarabine inhibits DNA polymerase, resulting in the inhibition of DNA replication in tumor cells. (NCI04) ( NCI )] (UMLS (NCI) C0042646) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
=adenosine;
arabinonucleoside;
[OP203] ANTIVIRALS, TOPICAL OPHTHALMIC;
=2-Fluoro-9-beta-arabinofuranosyladenine;
VIDARABINE 3 %;
126. 4-(3'-bromoanilino)-6,7-dimethoxyquinazoline
[A protein tyrosine kinase inhibitor that has specific activity for the epidermal growth factor receptor. (NCI) ( NCI )] (UMLS (NCI) C0258113) =Organic Chemical; Pharmacologic Substance
176. 90% + BDY BRN/10-19% 3RD
[ ] (UMLS (ICD9CM) C0161383) =Injury or Poisoning
127. 4-[bis(2-chloroethyl)amino]-L-phenylalanine
[4-bis-(2-chloroethyl)amino-L-phenylalanine; a bifunctional alkylating agent used as a DNA strand crosslinker and antineoplastic. ( CSP )] (UMLS (NCI) C0025241) =Amino Acid, Peptide, or Protein; Pharmacologic Substance ;
=[AN000] ANTINEOPLASTICS;
Bis(2-chloroethyl)methylamine;
Nitrogen Mustard Compound;
phenylalanine;
Antineoplastic Alkylating Agent;
=3-(p-(bis(2-chloroethyl)amino)phenyl)-L-Alanine, Hydrochloride;
MELPHALAN 2 MG;
177. 90% + BDY BRN/20-29% 3RD
[ ] (UMLS (ICD9CM) C0161384) =Injury or Poisoning
128. 40-49% BDY BRN/10-19% 3D
[ ] (UMLS (ICD9CM) C0161343) =Injury or Poisoning
178. 90% + BDY BRN/30-39% 3RD
[ ] (UMLS (ICD9CM) C0161385) =Injury or Poisoning
129. 40-49% BDY BRN/20-29% 3D
[ ] (UMLS (ICD9CM) C0161344) =Injury or Poisoning
179. 90% + BDY BRN/3D DEG NOS
[ ] (UMLS (ICD9CM) C0161382) =Injury or Poisoning
130. 40-49% BDY BRN/3 DEG NOS
[ ] (UMLS (ICD9CM) C0161342) =Injury or Poisoning
180. 90% + BDY BRN/40-49% 3RD
[ ] (UMLS (ICD9CM) C0161386) =Injury or Poisoning
131. 40-49% BDY BRN/30-39% 3D
[ ] (UMLS (ICD9CM) C0161345) =Injury or Poisoning
181. 90% + BDY BRN/50-59% 3RD
[ ] (UMLS (ICD9CM) C0161387) =Injury or Poisoning
132. 40-49% BDY BRN/40-49% 3D
[ ] (UMLS (ICD9CM) C0161346) =Injury or Poisoning
182. 90% + BDY BRN/60-69% 3RD
[ ] (UMLS (ICD9CM) C0161388) =Injury or Poisoning
133. 4B5 monoclonal antibody anti-idiotype vaccine
[A humanized anti-idiotypic (anti-Id) monoclonal antibody (MoAb) that mimics the disialoganglioside GD2, a cancer-associated antigen present on melanoma, small cell lung cancer, sarcoma, neuroblastoma and other malignancies. GD2 is a highly expressed glycosphingolipid by melanoma and other neuroectodermal tumors with only minimal expression on normal tissues. Vaccination with anti-Id 4B5 IgG was capable of eliciting both cellular and humoral immune responses against GD2 expression tumor cells. ( NCI )] (UMLS (NCI) C0879386) MoAb 4B5 anti-idiotype vaccine;
Monoclonal Antibody 4B5 Anti-Idiotype Vaccine =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Immunologic Factor
183. 90% + BDY BRN/70-79% 3RD
[ ] (UMLS (ICD9CM) C0161389) =Injury or Poisoning
134. 5 bromodeoxycytidine
[5-Bromo-2'-deoxycytidine. Can be incorporated into DNA in the presence of DNA polymerase, replacing dCTP. ( MSH )] (UMLS (CSP) C0006232) =Nucleic Acid, Nucleoside, or Nucleotide; Biologically Active Substance
184. 90% + BDY BRN/80-89% 3RD
[ ] (UMLS (ICD9CM) C0161390) =Injury or Poisoning
135. 5 bromodeoxyuridine
[nucleoside that substitutes for thymidine in DNA and thus acts as an antimetabolite; causes breaks in chromosomes and has been proposed as an antiviral and antineoplastic agent; it has been given orphan drug status for use in the treatment of primary brain tumors. ( CSP )] (UMLS (CSP) C0006233) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance =deoxyuridine;
halocarbon compound;
nucleoside analog;
185. 90% + BDY BRN/90% + 3RD
[ ] (UMLS (ICD9CM) C0161391) =Injury or Poisoning
136. 5 bromouracil
[5-bromo-2,4(1H,3H)-pyrimidinedione; brominated derivative of uracil that acts as an antimetabolite, substituting for thymine in DNA; used mainly as an experimental mutagen. ( CSP )] (UMLS (CSP) C0006242) =Nucleic Acid, Nucleoside, or Nucleotide; Hazardous or Poisonous Substance =uracil analog;
186. B
[Maxillary right first primary molar ( HL7V3.0 )] (UMLS (HL7) C0227088) =Body Part, Organ, or Organ Component =Primary dentition;
137. 5-(2-(4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-Indol-2-one Monohydrochloride
[The hydrochloride salt form of ziprasidone, a benzothiazolylpiperazine derivative and an atypical antipsychotic agent with an antischizophrenic property. Ziprasidone hydrochloride functions as an antagonist at the dopamine D2 and serotonin 5-HT2A and 5-HT1D receptors, and as an agonist at the 5-HT1A receptor. Ziprasidone hydrochloride also inhibits synaptic reuptake of serotonin and norepinephrine. The mechanism of action by which ziprasidone hydrochloride exerts its antischizophrenic effect is unknown but is potentially mediated through a combination of dopamine D2 and serotonin 5-HT2 antagonism. This agent also has antagonistic activity against histamine H1 and alpha-1-adrenergic receptors. ( NCI )] (UMLS (NCI) C0380392) =Organic Chemical; Pharmacologic Substance ;
187. B
[highly reactive nonmetallic trace element with the atomic symbol B, atomic number 5, and atomic weight 10.81; boron 10 is a stable isotope that emits gamma rays after neutron capture and is used in radiation detectors. ( CSP )] (UMLS (NCI) C0006030) =Element, Ion, or Isotope ;
=Element;
Micronutrient;
Inactive Ingredient Preparations;
=BORON 6 MG;
BORON 150 MCG
138. 5-(bis-(2-Chloroethyl) Amino) Uracil
[Nitrogen mustard derivative of URACIL. It is a alkylating antineoplastic agent that is used in lymphatic malignancies, and causes mainly gastrointestinal and bone marrow damage. ( MSH )] (UMLS (NCI) C0041920) =Nucleic Acid, Nucleoside, or Nucleotide; Pharmacologic Substance ;
=Nitrogen Mustard Compound;
2, 4-Dioxopyrimidine;
Antineoplastic Alkylating Agent;
188. B 859-35
(UMLS (NCI) C0285636) =Organic Chemical; Pharmacologic Substance ;
139. 5-[3, 3-Bis(2-chloroethyl)-1-triazeno]imidazole-4-carboxamide
[A synthetic derivative of imidazole with potent antineoplastic properties. Imidazole mustard alkylates DNA, preferentially at guanine residues, resulting in DNA interstrand crosslinks and inhibition of DNA replication and RNA and protein synthesis. (NCI04) ( NCI )] (UMLS (NCI) C0063382) =Organic Chemical; Pharmacologic Substance
189. B Cell
[lymphoid cells concerned with humoral immunity; they are short lived cells resembling bursa derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation. ( CSP )] (UMLS (NCI) C0004561) =Cell ;
140. 5-[[2-(2-Butoxyethoxy)ethoxy]methyl]-6-propyl-1,3-benzodioxole
[A synthetic derivative of benzodioxole and used as an insecticide synergist, Piperonyl Butoxide enhances the active properties of pyrethrin, pyrethroid, rotenone, and carbamate pesticide ingredients by inhibiting insect microsomal enzyme detoxification activity. It is toxic and suspected of causing anorexia, carcinogenesis, convulsions, and dermal irritation, as well as hepatic and renal damage. (NCI04) ( NCI )] (UMLS (NCI) C0031962) =Organic Chemical; Hazardous or Poisonous Substance =Dioxoles;
Pediculicide =PIPERONYL BUTOXIDE TECHNICAL;
PIPERONYL BUTOXIDE 3 %;
190. B cell acquired immunodeficiency
[ ] (UMLS (CSP) C1328844) =Disease or Syndrome ;
141. 50-59% BDY BRN/10-19% 3D
[ ] (UMLS (ICD9CM) C0161349) =Injury or Poisoning
191. B cell activating factor
[lymphokine produced by antigen or mitogen activated T lymphocytes that enhances the ability of B lymphocytes to present antigen, primes B lymphocytes to proliferate in response to anti-Ig and lipopolysaccharide, and regulates the production of IgG and IgE by B lymphocytes; it also acts as a growth factor for T lymphocytes and as a maturation factor for mast cells. ( CSP )] (UMLS (CSP) C0021758) =Amino Acid, Peptide, or Protein; Immunologic Factor =lymphokine;
hematopoietic growth factor
142. 50-59% BDY BRN/20-29% 3D
[ ] (UMLS (ICD9CM) C0161350) =Injury or Poisoning
192. B Cell Childhood Acute Lymphoblastic Leukemia
(UMLS (NCI) C0279584) =Neoplastic Process
143. 50-59% BDY BRN/3 DEG NOS
[ ] (UMLS (ICD9CM) C0161348) =Injury or Poisoning
193. B Cell Chronic Lymphocytic Leukemia
[A slowly progressing disease in which too many white blood cells (called lymphocytes) are found in the body. ( NCI )] (UMLS (NCI) C0023434) =Neoplastic Process ;
=Leukemia, Lymphocytic;
=Acute B Cell Lymphocytic Leukemia;
Leukemia, B-Cell, Chronic;
Leukemia, Pre-B-Cell;
144. 50-59% BDY BRN/30-39% 3D
[ ] (UMLS (ICD9CM) C0161351) =Injury or Poisoning
194. B cell differentiation factor
[cytokine produced by antigen or mitogen activated T lymphocytes, fibroblasts and macrophages that serves as a differentiation factor for lymphocytes and stimulates immunoglobulin production by B lymphocytes; it also innitiates the cell cycle in primitive hematopoietic cells in vitro. ( CSP )] (UMLS (CSP) C0021760) =Amino Acid, Peptide, or Protein; Immunologic Factor =Cytokine;
hematopoietic growth factor
145. 50-59% BDY BRN/40-49% 3D
[ ] (UMLS (ICD9CM) C0161352) =Injury or Poisoning
195. B Cell Differentiation Factor I
[lymphokine produced by antigen or mitogen activated T lymphocytes that acts as a differentiation factor for B lymphocytes and eosinophils and increases the production of IgA by B lymphocytes. ( CSP )] (UMLS (NCI) C0021759) =Amino Acid, Peptide, or Protein; Immunologic Factor =lymphokine;
hematopoietic growth factor
146. 50-59% BDY BRN/50-59% 3D
[ ] (UMLS (ICD9CM) C0161353) =Injury or Poisoning
196. B cell inborn immunodeficiency
[ ] (UMLS (CSP) C1328845) =Disease or Syndrome ;
147. 6,7 benzomorphan
[ ] (UMLS (CSP) C0178433) =Organic Chemical ;
=morphinan;
=cyclazocine;
PENTAZOCINE
197. B Cell Linker Protein
[B-Cell Linker, encoded by the BLNK gene, is essential for normal B-cell development. This protein interfaces the B-cell receptor-associated SYK tyrosine kinase with PLC-gamma, the VAV guanine nucleotide exchange factor, and the GRB2 and NCK adaptor proteins. Tyrosine phosphorylation of B-Cell Linker by SYK provides docking sites for these SH2-containing effector molecules that, in turn permits the phosphorylation and/or activation of their respective signaling pathways. Thus, B-Cell Linker represents a central linker protein that bridges the B-cell receptor-associated kinases with a multitude of signaling pathways and may regulate biologic outcomes of B-cell function and development. The somatic loss of the BLNK gene and the accompanying block in pre-B-cell differentiation might be one of the primary causes of childhood pre-B ALL. (From OMIM and NCI) ( NCI )] (UMLS (NCI) C0756331) B-Cell Linker;
B-Cell Linker Protein;
BLNK;
=Amino Acid, Peptide, or Protein; Immunologic Factor
148. 60-69% BDY BRN/10-19% 3D
[ ] (UMLS (ICD9CM) C0161356) =Injury or Poisoning
198. B cell lymphoma
[any in a large group of nonHodgkin's lymphoma's characterized by malignant transformation of the B lymphocytes. ( CSP )] (UMLS (CSP) C0079731) =Neoplastic Process =Lymphoma, Non-Hodgkin;
=Acute B Cell Lymphocytic Leukemia;
Lymphoma, Small-Cell;
AIDS Lymphoma;
Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue
149. 60-69% BDY BRN/20-29% 3D
[ ] (UMLS (ICD9CM) C0161357) =Injury or Poisoning
199. B Cell Lymphoma Stage II
[Stage II NHL means involvement of two or more lymph node regions on the same side of the diaphragm (II) or localized involvement of a single associated extralymphatic organ or site and its regional lymph nodes with or without other lymph node regions on the same side of the diaphragm (IIE). Note: The number of lymph node regions involved may be indicated by a subscript (e.g., II3). (PDQ) ( NCI )] (UMLS (NCI) C0855092) B-Cell Lymphoma Stage II;
Stage II B Cell Lymphoma;
Stage II B-Cell Lymphoma;
Stage II B-Cell Non-Hodgkin Lymphoma;
Stage II B-Cell Non-Hodgkin's Lymphoma =Neoplastic Process
150. 60-69% BDY BRN/3 DEG NOS
[ ] (UMLS (ICD9CM) C0161355) =Injury or Poisoning
200. B Cell Lymphoma Stage III
[Stage III NHL means involvement of lymph node regions on both sides of the diaphragm (III) that may also be accompanied by localized involvement of an extralymphatic organ or site (IIIE), by involvement of the spleen (IIIS), or both (IIIS+E). (PDQ) ( NCI )] (UMLS (NCI) C0855093) B-Cell Lymphoma Stage III;
Stage III B Cell Lymphoma;
Stage III B-Cell Lymphoma;
Stage III B-Cell Non-Hodgkin Lymphoma;
Stage III B-Cell Non-Hodgkin's Lymphoma =Neoplastic Process

Buy website

Medical Clinic. Optician. Pharmacy. Physician. Travel Agency. Hotel reservation. Child Care. Education. Teachers. Lessons. Tests and Exams. Certification. Shopping Center. Store. Real Estate.
Affordable prices from $100.

 home Dictionaries Armenian-English English-Armenian MeSH Feedback  top
© 2008 -2011 Administrator MEDINDEX.AM